Single-cell RNA sequencing reveals population-based shifts in gene expression heterogeneity in an unstable, clonally derived CHO cell line
- PMID: 41803018
- DOI: 10.1002/btpr.88502
Single-cell RNA sequencing reveals population-based shifts in gene expression heterogeneity in an unstable, clonally derived CHO cell line
Abstract
The genomic plasticity of Chinese Hamster Ovary cells allows them to be genetically engineered to produce foreign proteins with high specific productivities while placing a significant burden on their ability to retain this expression capacity over time. Many cell lines lose expression over time and need to be screened for expression consistency. Stability has been studied in clonally derived cell cultures by evaluating phenotypic heterogeneity in subclones derived from stable or unstable clones, but not well characterized within the primary, clonally derived cell culture. To address this, we employed single cell RNA sequencing in stable and unstable cell lines expressing the same monoclonal antibody, at early and late timepoints in their manufacturing lifespan. We observed higher expression heterogeneity and a more drastic redistribution of expression profile "clusters" over serial passaging in the unstable cell line. Differentially expressed genes in those clusters making up the unstable cell line suggest distinct changes in metabolic pathway activity in this cell line over time. Using molecular methods, changing gene expression profiles were confirmed and activation of molecular pathways consistent with a challenged protein homeostasis were shown to be enriched in cells over time in the unstable cell line. This report more broadly implicates the role of heterogeneity within a clonal population as a contributing factor to cell line instability, providing a biological context for further investigation.
Keywords: CHO cells; ScRNAseq; cellular aging; clonal population; gene expression regulation; metabolic stress; population heterogeneity; single cell transcriptome analysis.
© 2026 American Institute of Chemical Engineers.
References
REFERENCES
-
- Clarke H, Mayer‐Bartschmid A, Zheng C, et al. When will we have a clone? An industry perspective on the typical CLD timeline. Biotechnol Prog. 2024;40(4):e3449.
-
- Frye C, Deshpande R, Estes S, et al. Industry view on the relative importance of “clonality” of biopharmaceutical‐producing cell lines. Biologicals. 2016;44(2):117‐122.
-
- Patel NA, Anderson CR, Terkildsen SE, et al. Antibody expression stability in CHO clonally derived cell lines and their subclones: role of methylation in phenotypic and epigenetic heterogeneity. Biotechnol Prog. 2018;34(3):635‐649.
-
- Wurm FM. CHO Quasispecies‐implications for manufacturing processes. Processes. 2013;1(3):296‐311.
-
- Q5B Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r‐DNA Derived Protein Products. Federal Register; 1996:7006‐7008.
LinkOut - more resources
Full Text Sources
